Gyre Therapeutics (GYRE) Net Cash Flow Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 89.97% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -13.44% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 33.37% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -29.82% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 32.17% |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn | 26.69% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.69% |
| Dec 31, 2025 | 49.64% |
| Sep 30, 2025 | 27.47% |
| Jun 30, 2025 | -19.16% |
| Mar 31, 2025 | 32.65% |
| Dec 31, 2024 | 36.47% |
| Sep 30, 2024 | 71.44% |
| Jun 30, 2024 | -13.04% |
| Mar 31, 2024 | -27.44% |
| Dec 31, 2023 | 54.21% |
| Sep 30, 2023 | 26.42% |
| Jun 30, 2023 | 14.15% |
| Mar 31, 2023 | -27.87% |
| Dec 31, 2022 | -52.06% |
| Sep 30, 2022 | -124.45% |
| Jun 30, 2022 | 93.87% |
| Mar 31, 2022 | -15.48% |
| Dec 31, 2021 | -45.73% |
| Sep 30, 2021 | -10.71% |
| Jun 30, 2021 | 50.98% |
| Mar 31, 2021 | -21.02% |
| Dec 31, 2020 | 20.54% |
| Sep 30, 2020 | -16.57% |
| Jun 30, 2020 | -44.37% |
| Mar 31, 2020 | 189.72% |
| Dec 31, 2019 | -116.00% |
| Sep 30, 2019 | 68.54% |
| Jun 30, 2019 | 6.54% |
| Mar 31, 2019 | 10.09% |
| Dec 31, 2018 | -40.90% |
| Sep 30, 2018 | -35.95% |
| Jun 30, 2018 | -597.70% |
| Mar 31, 2018 | 488.35% |
| Dec 31, 2017 | 51.94% |
| Sep 30, 2017 | -56.47% |
| Jun 30, 2017 | 106.21% |
| Mar 31, 2017 | 36.10% |
| Dec 31, 2016 | -63.78% |
| Sep 30, 2016 | -15.16% |
| Jun 30, 2016 | -11.39% |
| Mar 31, 2016 | 11.72% |
| Dec 31, 2015 | 14.11% |
| Sep 30, 2015 | 46.91% |
| Jun 30, 2015 | 26.28% |
| Mar 31, 2015 | 26.58% |
| Dec 31, 2014 | 55.43% |
| Sep 30, 2014 | 32.29% |
| Jun 30, 2014 | -27.15% |
| Mar 31, 2014 | 29.56% |
| Dec 31, 2013 | 44.21% |
| Sep 30, 2013 | 66.72% |